Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk

Description

The study is a prospective, observational study evaluating the utility of endoscopic ultrasound or MRI for the identification of preneoplastic and neoplastic pancreatic lesions in patients at high risk for pancreatic cancer, specifically those with BRCA1/2, ATM, or PALB2 mutations.

Conditions

Pancreatic Cancer

Study Overview

Study Details

Study overview

The study is a prospective, observational study evaluating the utility of endoscopic ultrasound or MRI for the identification of preneoplastic and neoplastic pancreatic lesions in patients at high risk for pancreatic cancer, specifically those with BRCA1/2, ATM, or PALB2 mutations.

Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk

Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk

Condition
Pancreatic Cancer
Intervention / Treatment

-

Contacts and Locations

Philadelphia

Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States, 19004

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    18 Years to

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    No

    Collaborators and Investigators

    Abramson Cancer Center at Penn Medicine,

    Study Record Dates

    2028-05